196 Results for "

LSDs

" in MedChemExpress (MCE) Product Catalog:
Products (196)

196 Results for "LSDs" in MCE Product Catalog:

Cat. No.: HY-122635
CAS No.: 1597426-52-2
Target:  

Histone Demethylase

Domaines de recherche:  

Neurological Disease

T-448 free base is a specific, orally active, CNS-penetrant and irreversible inhibitor of lysine-specific demethylase 1 (LSD1, an H3K4 demethylase), with an IC50 of 22 nM. T-448 free base enhances H3K4 methylation in primary cultured rat neurons .
loading...
    loading...
Cat. No.: HY-W742532
CAS No.: 65527-62-0
Synonyms: N-Ethyl-nor-LSD
Domaines de recherche:  

Neurological Disease

ETH-LAD (N-Ethyl-nor-LSD) is an activator for 5-HT2A receptor with Ki of 5.1 nM. ETH-LAD exhibits affinity for dopamine receptor D1 and dopamine receptor D2 with Ki of 22.1 nM and 4.4 nM. ETH-LAD acts as psychoactive substance in rat model .
loading...
    loading...
Cat. No.: HY-155526
CAS No.: 3049681-20-8
Target:  

Histone Demethylase

Domaines de recherche:  

Cancer

FY-21 is a selective inhibitor of LSD1 (IC50=340 nM), with anti-proliferation and anti-colony formation activities. FY-21 enhances p53 expression, down-regulates HOXA9 and MEIS1 expression. FY-21 also induces leukemia cell differentiation to exhibts antitumor activity .
loading...
    loading...
Cat. No.: HY-169791
CAS No.: 2349367-50-4
Target:  

5-HT Receptor

Domaines de recherche:  

Neurological Disease

ECPLA, a lysergamide lysergic acid diethylamidean (LSD) analog, is a potent 5-HT2A agonist (EC50 of 14.6 nM) for Gq-mediated calcium flux. ECPLA has high affinity for most serotonin receptors, α2-adrenoceptors, and D2-like dopamine receptors .
loading...
    loading...
Cat. No.: HY-155825
CAS No.: 1637373-70-6
Domaines de recherche:  

Cancer

LPE-1 is a lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 of 0.65 μM. LPE-1 inhibits the proliferation of gastric cancer, liver cancer and prostate cancer cells, and shows no activity against a subset of gastric cancer cells. LPE-1 is applicable for the research of gastric cancer, liver cancer and prostate cancer .
loading...
    loading...
Cat. No.: HY-179230
CAS No.: 2451247-91-7
Domaines de recherche:  

Cancer

E3 Ligase Ligand-linker Conjugate 214 is an E3 ligase ligand-linker conjugate containing a Von Hippel-Lindau (VHL) ligand and a linker. E3 Ligase Ligand-linker Conjugate 214 can bind to a target protein ligand to form a PROTAC molecule, PROTAC LSD1 Degrader 1 (HY-179229) .
loading...
    loading...
Cat. No.: HY-19333A
CAS No.: 1357299-45-6
Domaines de recherche:  

Infection

OG-L002 hydrochloride is a potent and highly selective LSD1 inhibitor with an IC50 of 0.02 μM. OG-L002 hydrochloride is a potent monoamine oxidases (MAO) inhibitor with IC50s of 1.38 μM and 0.72 μM for MAO-A and MAO-B, respectively. OG-L002 hydrochloride potently inhibits the expression of HSV IE genes .
loading...
    loading...
Cat. No.: HY-141677
CAS No.: 1802909-49-4
Pureté:  98.06%
Target:  

Histone Demethylase

Domaines de recherche:  

Cancer

INCB059872 is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor that achieves inhibitory activity through the formation of covalent FAD-adducts. INCB059872 can inhibit cell proliferation and induce cell differentiation by upregulating the expression of myeloid differentiation markers CD86 and CD11b. INCB059872 can be used for the research of myeloid leukemia .
loading...
    loading...
Cat. No.: HY-141677A
CAS No.: 3062683-32-0
Pureté:  99.18%
Target:  

Histone Demethylase

Domaines de recherche:  

Cancer

INCB059872 dihydrochloride is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor that achieves inhibitory activity through the formation of covalent FAD-adducts. INCB059872 dihydrochloride can inhibit cell proliferation and induce cell differentiation by upregulating the expression of myeloid differentiation markers CD86 and CD11b. INCB059872 dihydrochloride can be used for the research of myeloid leukemia .
loading...
    loading...
Cat. No.: HY-141677B
CAS No.: 2081940-67-0
Target:  

Histone Demethylase

Domaines de recherche:  

Cancer

INCB059872 tosylate is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor that achieves inhibitory activity through the formation of covalent FAD-adducts. INCB059872 tosylate can inhibit cell proliferation and induce cell differentiation by upregulating the expression of myeloid differentiation markers CD86 and CD11b. INCB059872 tosylate can be used for the research of myeloid leukemia .
loading...
    loading...
Cat. No.: HY-B1496R
CAS No.: 13492-01-8
Synonyms: SKF 385 hemisulfate (Standard)
Tranylcypromine (hemisulfate) (Standard) is the analytical standard of Tranylcypromine (hemisulfate). This product is intended for research and analytical applications. Tranylcypromine (SKF 385) hemisulfate is an irreversible, nonselective monoamine oxidase (MAO) inhibitor used in the treatment of depression. Tranylcypromine hemisulfate is also a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis. Tranylcypromine has antidepressant effects .
loading...
    loading...
Cat. No.: HY-141677C
CAS No.: 1802909-50-7
Target:  

Histone Demethylase

Domaines de recherche:  

Cancer

INCB059872 TFA is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor that achieves inhibitory activity through the formation of covalent FAD-adducts. INCB059872 TFA can inhibit cell proliferation and induce cell differentiation by upregulating the expression of myeloid differentiation markers CD86 and CD11b. INCB059872 TFA can be used for the research of myeloid leukemia .
loading...
    loading...
Cat. No.: HY-N18236
CAS No.: 2538955-98-3
3β-Acetoxyl-atractylenolide I is a LSD1 inhibitor with an IC50 of 57 μM. 3β-Acetoxyl-atractylenolide I blocks tumor growth, metastasis and invasion. 3β-Acetoxyl-atractylenolide I is used in the research of various cancers including prostate cancer, breast cancer, neuroblastoma, gastric cancer, colon cancer, bladder cancer, esophageal cancer, acute myeloid leukemia and retinoblastoma .
loading...
    loading...
Cat. No.: HY-161470
CAS No.: 2247544-03-0
WS-384 is a dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor with oral activity, with IC50 values of 338.79 nM and 14.81 nM, respectively. WS-384 possesses anticancer activity and can cause cell cycle arrest, DNA damage, and induce apoptosis. WS-384 can be used in the research of non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-168968S
CAS No.: 3091379-82-4
ZJY-54 is an orally active dual-target inhibitor of EGFR/LSD1, with IC50 values of 3.8 nM and 0.6 μM, respectively. ZJY-54 can inhibit the proliferation of non-small cell lung cancer cells, induce the accumulation of H3K4me2 and H3K9me2, and inhibit the phosphorylation of the EGFR signaling pathway. ZJY-54 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-103713AR
CAS No.: 2044953-70-8
Synonyms: SP-2577 mesylate (Standard)
Domaines de recherche:  

Cancer

Seclidemstat mesylate (Standard) is the analytical standard of Seclidemstat mesylate (HY-103713A). This product is intended for research and analytical applications. Seclidemstat (SP-2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor (Ki=31 nM, IC50=13 nM). Seclidemstat mesylate promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer, as well as inhibit virus production, viral DNA replication, and late gene expression. Seclidemstat mesylate can be used for the research of Ewing Sarcoma .
loading...
    loading...
Cat. No.: HY-103713R
CAS No.: 1423715-37-0
Synonyms: SP-2577 (Standard)
Domaines de recherche:  

Cancer

Seclidemstat (Standard) is the analytical standard of Seclidemstat (HY-103713). This product is intended for research and analytical applications. Seclidemstat is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor (Ki=31 nM, IC50=13 nM). Seclidemstat promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer, as well as inhibit virus production, viral DNA replication, and late gene expression. Seclidemstat can be used for the research of Ewing Sarcoma .
loading...
    loading...
Cat. No.: HY-109169AR
CAS No.: 1990504-72-7
Synonyms: IMG-7289 ditosylate (Standard)
Domaines de recherche:  

Cancer

Bomedemstat ditosylate (Standard) is the analytical standard of Bomedemstat (ditosylate) (HY-109169A). This product is intended for research and analytical applications. Bomedemstat (IMG-7289) ditosylate is an orally active and irreversible lysine-specific demethylase 1 (LSD1) inhibitor. Bomedemstat ditosylate can increase H3K4 and H3K9 methylation, and then alter gene expression. Bomedemstat ditosylate shows anti-cancer activities, inhibits cancer cell proliferation and induces apoptosis .
loading...
    loading...
Cat. No.: HY-169841
CAS No.: 2957888-70-7
Target:  

5-HT Receptor Arrestin

Domaines de recherche:  

Neurological Disease

IHCH-7086 is a blood-brain barrier-permeable, partial β-arrestin-biased agonist of 5-HT2AR with a Ki of 12.59 nM. IHCH-7086 blocks D-lysergic acid diethylamide-induced head-twitch response in mice and alleviates depression-like behaviors in mice subjected to acute restraint stress or injected with Corticosterone (HY-B1618). IHCH-7086 is applicable to research related to depression .
loading...
    loading...
Cat. No.: HY-136522
CAS No.: 2262489-89-2
Pureté:  98.15%
Domaines de recherche:  

Cancer

S2116, a N-alkylated tranylcypromine (TCP) derivative, is a potent lysine-specific demethylase 1 (LSD1) inhibitor. S2116 increases H3K9 methylation and reciprocal H3K27 deacetylation at super-enhancer regions. S2116 induces apoptosis in TCP-resistant T-cell acute lymphoblastic leukemia (T-ALL) cells by repressing transcription of the NOTCH3 and TAL1 genes. S2116 significantly retardes the growth of T-ALL cells in xenotransplanted mice .
loading...
    loading...